Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Star polymers for PET/MRI: a passive pretargeting approach

Jeroen Goos, Simon Puttick, Thomas Dilling, Abhishek Gupta, William Price, John Quinn, Michael Whittaker, Jason Lewis and Thomas Davis
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 195;
Jeroen Goos
1Memorial Sloan Kettering Cancer Center New York NY United States
2Monash University Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Puttick
3University of Queensland Brisbane Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Dilling
1Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishek Gupta
4Western Sydney University Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Price
4Western Sydney University Sydney Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Quinn
2Monash University Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Whittaker
2Monash University Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Lewis
1Memorial Sloan Kettering Cancer Center New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Davis
2Monash University Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

195

Objectives: The pretargeting approach, in which a targeting ligand is allowed to accumulate at the target site before a small effector molecule is injected, has successfully been applied to enhance specificity and reduce off-target radiation dose in positron emission tomography (PET) imaging and radioimmunotherapy. To enable accumulation at the target site without the need to rely on receptor availability, passive targeting may be preferred. Nanoparticles may utilize the enhanced permeability and retention (EPR) effect that is often associated with solid tumors. Not only will such nanoparticles exploit the advantages of pretargeting, they also profit from the increased availability of binding sites for the radiolabeled effector, as well as allow for multimodality imaging, combining PET with magnetic resonance imaging (MRI).

Methods: Via RAFT polymerization, a star-shaped copolymer was synthesized, consisting of oligoethylene glycol methyl ether acrylate (OEGA) units, 2-vinyl-4,4-dimethyl-5-oxazolone (VDM) units modified with [Gd3+]1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid)-10-(aminoethylacetamide) ([Gd3+]DO3A) and aminoethyl acrylate (AEA) units modified with either deferoxamine (DFO) or trans-cyclooctene (TCO). The DFO-conjugated star polymer was radiolabeled with 89Zr, whereas the TCO-conjugated star polymer was used for pretargeting with [18F]F-tetrazine-poly(ethylene glycol)11-1,4,7-triazacyclononane-1,4-diacetic acid ([18F]F-Tz-PEG11-NODA).1 Biodistribution and bioorthogonal ligation will be assessed in athymic nude mice carrying subcutaneous BxPC3 xenografts. 1H longitudinal relaxivities were determined over a continuum of magnetic field strengths ranging from 0.24 mT - 0.94 T at 37 °C (nuclear magnetic relaxation dispersion (NMRD) profile). RESULTS: The star polymer (84 kDa, PDI = 1.16, Dh = 11 nm) consisted of 7 to 8 cross-linked polymer arms, each containing approximately 19×OEGA repeat units, 5×VDM-[Gd3+]DO3A units and 4×AEA-DFO or AEA-TCO units. Radiolabeling of the star polymer with 89Zr was achieved with high radiochemical yield (>99%) and purity (>99%) and high molar activity (>290 GBq µmol-1). Accumulation of the star polymers in BxPC3 xenografts and bioorthogonal click efficiency will be discussed. The NMRD profile was typical of a paramagnetic nanoparticle, with maximal relaxivity (16.9 mM-1s-1) at ~30 MHz. CONCLUSIONS: Star-shaped nanoparticles were developed in which passive pretargeting PET imaging is combined with MRI. Such nanoparticles minimize the radiation dose to healthy tissues, while offering increased sensitivity and specificity as well as improved tissue contrast.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Star polymers for PET/MRI: a passive pretargeting approach
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Star polymers for PET/MRI: a passive pretargeting approach
Jeroen Goos, Simon Puttick, Thomas Dilling, Abhishek Gupta, William Price, John Quinn, Michael Whittaker, Jason Lewis, Thomas Davis
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 195;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Star polymers for PET/MRI: a passive pretargeting approach
Jeroen Goos, Simon Puttick, Thomas Dilling, Abhishek Gupta, William Price, John Quinn, Michael Whittaker, Jason Lewis, Thomas Davis
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 195;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Novel Multimodality and Nonradioactive Probes

  • 800CW Dye and 89Zr Dual-labeled Antibody for the PET/NIRF/Cerenkov Multi-modality Imaging of ICAM-1 (CD54) in Pancreatic Cancer
  • Trimodal molecular imaging using a broad-spectrum metal attaching ultra-small quantum dots
  • Organic melanin nanoparticles targeting somatostatin receptor subtype 2 and Multimodality imaging for human small cell lung cancer xenograft model
Show more Novel Multimodality and Nonradioactive Probes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire